Anti-tumor activity of mTOR inhibitor temsirolimus for relapsed mantle cell lymphoma: A phase II trial in the North Central Cancer Treatment Group
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Mayo Clinic, Iowa Oncology Research Association
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2275219352
